Josh Enomoto

Josh Enomoto

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Why Polkadot Climbed Up the Ranks of the Cryptocurrency Market

Seemingly out of nowhere, Polkadot and specifically its DOT blockchain token has emerged as a top cryptocurrency player. Here’s what you need to know about this fresh-faced crypto coin.

CCIV Stock’s SPAC Circus Is Just Background Noise

CCIV stock may be overpriced right now, but if you believe in the EV rollout its underlying business makes sense. CCIV is making Tesla look in the rearview mirror.

8 Risky Stocks to Buy If Danger Is Your Middle Name

With the market at incredibly frothy valuations, buying into speculative ventures isn’t for everyone. Still, if you can handle the potential volatility, these risky stocks to buy may have more room to run.

Why Tenaris Just Might Benefit From ‘Grid’ Anxiety

With both traditional and green energy power infrastructures taking a hit, perhaps grid anxiety could help boost TS stock.

With Cryptos Sinking, It’s Time To Exit Riot Blockchain Stock Positions

With cryptocurrencies receiving an influx of institutional money, RIOT stock benefitted handsomely. However, if those institutions exit, the red ink could be disastrous.

Workhorse May Have a Texas-Sized ‘Bitcoin Problem’

While WKHS stock was seemingly a shoo-in for a USPS contract boost, the Texas winter storm imposed a damper on that thesis.

8 Medical Marijuana Stocks That Are Just What the Doctor Ordered

With many people seeking natural therapies to address pandemic-related stress, the backdrop is favorable for marijuana stocks.

The Problem With Carnival Is That Customers Have Long Memories

On the surface, CCL stock might appear a contrarian opportunity based off encouraging Covid-19 vaccine results. However, lingering fears may end up hurting shares for a while longer.

Why Devastation Now in SunPower Could Produce Gains Later

What the devastation of the Texas winter storm exposed was the underlying concept of SPWR stock -- solar energy is intermittent. But longer term, the volatility could be a great entry point.

The Narrative for Koss Is More Interesting Than Its Shares

A broader mental fracturing has caused KOSS stock to rise to ridiculous valuations, only to plummet down to earth. Let that be a permanent lesson that you don’t have friends on Wall Street.